@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-K3F1QFBQ-N
  skos:prefLabel "Digoxigenin"@en, "Digoxigénine"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-KK47152P-8 .

jvr:-XR6MT7ZV-V
  skos:prefLabel "Cardiotoniques"@fr, "Cardiotonic Agents"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-S3R185SD-K
  skos:prefLabel "Médigoxine"@fr, "Medigoxin"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-KK47152P-8 .

jvr:-DH8ZBHPD-T
  skos:prefLabel "Glucosides digitaliques"@fr, "Digitalis Glycosides"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-KK47152P-8 .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-KK47152P-8
  dc:established "1966-01-01"^^xsd:date ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D004077> ;
  skos:hiddenLabel "Digitek"@en, "Digoxine Nativelle"@en, "Mapluxin"@en, "Lanoxin-PG"@en, "Lanicor"@en, "Digacin"@en, "Digoxina Boehringer"@en, "Dilanacin"@en, "Hemigoxine Nativelle"@en, "Digoregen"@en, "Lanoxicaps"@en, "Lenoxin"@en, "Lanoxin"@en, "Lanacordin"@en ;
  skos:definition "A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666)"@en ;
  mesh:allowableQualifier jvr:-W6SQV79N-S, jvr:-WK5F724J-1, jvr:-H7K65Q8S-Z, jvr:-T9HQD7ST-J, jvr:-Q3979798-W, jvr:-G4R176S9-J, jvr:-FWD2BGQ0-9, jvr:-L6C0XPHT-4, jvr:-HQRFT0C6-B, jvr:-M63HSDM7-1, jvr:-CB30NGKB-3, jvr:-TJHVZCRZ-0, jvr:-R0ZCQ8X6-J, jvr:-R3QWLHRG-V, jvr:-NB0XHT3S-N, jvr:-BT300B3G-Q, jvr:-NFTHND7Q-8, jvr:-D0F21513-5, jvr:-NKM836P1-M, jvr:-THHNVC7V-3, jvr:-S0CS1X5R-5, jvr:-NHL3D2X0-S, jvr:-SBNWSM1T-R, jvr:-G30ZJ446-J, jvr:-XV06LPML-W ;
  skos:broader jvr:-DH8ZBHPD-T ;
  a skos:Concept, mesh:Descriptor ;
  skos:narrower jvr:-K3F1QFBQ-N, jvr:-ZGR444T5-C, jvr:-S3R185SD-K ;
  skos:prefLabel "Digoxine"@fr, "Digoxin"@en ;
  dc:created "1999-01-01"^^xsd:date ;
  dc:modified "2017-05-24"^^xsd:date ;
  skos:altLabel "Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-"@fr, "Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-"@en, "73K4184T59"@fr, "73K4184T59"@en, "20830-75-5 (Digoxin)"@en, "20830-75-5 (Digoxin)"@fr ;
  mesh:pharmacologicalAction jvr:-XR6MT7ZV-V, jvr:-LS0SSBHQ-R, jvr:-RNN9WKG8-L ;
  skos:inScheme jvr: .

jvr:-ZGR444T5-C
  skos:prefLabel "Acétyldigoxine"@fr, "Acetyldigoxins"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-KK47152P-8 .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-LS0SSBHQ-R
  skos:prefLabel "Anti-Arrhythmia Agents"@en, "Antiarythmiques"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-RNN9WKG8-L
  skos:prefLabel "Enzyme Inhibitors"@en, "Antienzymes"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .